Skip to main content
Top
Published in: International Cancer Conference Journal 2/2024

Open Access 06-02-2024 | Case Report - Pathology

Primary signet-ring cell carcinoma of the bladder treated with laparoscopic radical cystectomy: a case report

Authors: Yuta Mukae, Kojiro Ohba, Kyohei Araki, Yuichiro Nakamura, Hiromi Nakanishi, Takuji Yasuda, Kensuke Mitsunari, Tomohiro Matsuo, Yasushi Mochizuki, Junji Irie, Ryoichi Imamura

Published in: International Cancer Conference Journal | Issue 2/2024

Login to get access

Abstract

Primary bladder adenocarcinomas comprise 0.5–2% of all epithelial bladder neoplasms. Of these, primary signet-ring cell carcinoma of the bladder is particularly rare, accounting for 0.24% of all bladder malignancies. This tumor is frequently diagnosed at an advanced stage and has a poor prognosis. No standard treatment has yet been established. We here report a patient in whom laparoscopic cystectomy following neoadjuvant chemotherapy was effective. Our patient was a 69-year-old man who had had microscopic hematuria, undergone transurethral resection of a mass in the bladder, and been diagnosed pathologically with a primary signet-ring cell carcinoma of the bladder. No metastases were detected on computed tomography. The patient was treated with a combination of paclitaxel, cisplatin, and gemcitabine prior to undergoing laparoscopic cystectomy. The histopathological diagnosis on this operative specimen was dysplasia and no metastases were detected in the dissected lymph nodes. Complete remission has now been maintained for 9 years.
Literature
2.
go back to reference Thomas DG, Ward AM, Williams JL (1971) A study of 52 cases of adenocarcinoma of the bladder. Br J Urol 43(1):4–15CrossRefPubMed Thomas DG, Ward AM, Williams JL (1971) A study of 52 cases of adenocarcinoma of the bladder. Br J Urol 43(1):4–15CrossRefPubMed
3.
go back to reference Torenbeek R, Koot RA, Blomjous CE et al (1996) Primary signet-ring cell carcinoma of the urinary bladder. Histopathology 28(1):33–40CrossRefPubMed Torenbeek R, Koot RA, Blomjous CE et al (1996) Primary signet-ring cell carcinoma of the urinary bladder. Histopathology 28(1):33–40CrossRefPubMed
4.
go back to reference Akamatsu S, Takahashi A, Ito M et al (2010) Primary signet-ring cell carcinoma of the urinary bladder. Urology 75(3):615–618CrossRefPubMed Akamatsu S, Takahashi A, Ito M et al (2010) Primary signet-ring cell carcinoma of the urinary bladder. Urology 75(3):615–618CrossRefPubMed
5.
6.
go back to reference Michels J, Barbour S, Cavers D et al (2010) Metastatic signet-ring cell cancer of the bladder responding to chemotherapy with capecitabine: case report and review of literature. Can Urol Assoc J 4(2):E55-57CrossRefPubMedPubMedCentral Michels J, Barbour S, Cavers D et al (2010) Metastatic signet-ring cell cancer of the bladder responding to chemotherapy with capecitabine: case report and review of literature. Can Urol Assoc J 4(2):E55-57CrossRefPubMedPubMedCentral
7.
go back to reference Tang K, Li H, Xia D et al (2014) Laparoscopic versus open radical cystectomy in bladder cancer: a systematic review and meta-analysis of comparative studies. PLoS One 9(5):e95667ADSCrossRefPubMedPubMedCentral Tang K, Li H, Xia D et al (2014) Laparoscopic versus open radical cystectomy in bladder cancer: a systematic review and meta-analysis of comparative studies. PLoS One 9(5):e95667ADSCrossRefPubMedPubMedCentral
8.
go back to reference Ghoneim MA, Abdel-Latif M, el-Mekresh M, et al (2008) Radical cystectomy for carcinoma of the bladder: 2720 consecutive cases 5 years later. J Urol 180(1):121–127CrossRefPubMed Ghoneim MA, Abdel-Latif M, el-Mekresh M, et al (2008) Radical cystectomy for carcinoma of the bladder: 2720 consecutive cases 5 years later. J Urol 180(1):121–127CrossRefPubMed
9.
go back to reference Scosyrev E, Ely BW, Messing EM et al (2011) Do mixed histological features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer? A secondary analysis of Southwest Oncology Group-Directed Intergroup Study (S8710). BJU int 108(5):693–699CrossRefPubMed Scosyrev E, Ely BW, Messing EM et al (2011) Do mixed histological features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer? A secondary analysis of Southwest Oncology Group-Directed Intergroup Study (S8710). BJU int 108(5):693–699CrossRefPubMed
10.
go back to reference Hirano Y, Suzuki K, Fujita K et al (2002) Primary signet ring cell carcinoma of the urinary bladder successfully treated with intra-arterial chemotherapy alone. Urology 59(4):601CrossRefPubMed Hirano Y, Suzuki K, Fujita K et al (2002) Primary signet ring cell carcinoma of the urinary bladder successfully treated with intra-arterial chemotherapy alone. Urology 59(4):601CrossRefPubMed
11.
go back to reference Shringarpure SS, Thachil JV, Raja T et al (2011) A case of signet ring cell adenocarcinoma of the bladder with spontaneous urinary extravasation. Indian J Urol 27(3):401–403CrossRefPubMedPubMedCentral Shringarpure SS, Thachil JV, Raja T et al (2011) A case of signet ring cell adenocarcinoma of the bladder with spontaneous urinary extravasation. Indian J Urol 27(3):401–403CrossRefPubMedPubMedCentral
12.
go back to reference Singh J, Zherebitskiy V, Grynspan D et al (2012) Metastatic signet ring cell adenocarcinoma of the bladder: responsive to treatment? Can Urol Assoc J 6(1):E15-19CrossRefPubMedPubMedCentral Singh J, Zherebitskiy V, Grynspan D et al (2012) Metastatic signet ring cell adenocarcinoma of the bladder: responsive to treatment? Can Urol Assoc J 6(1):E15-19CrossRefPubMedPubMedCentral
13.
go back to reference El Ammari JE, Ahsaini M, Riyach O et al (2013) Primary signet-ring cell carcinoma of the urinary bladder successfully managed with cisplatin and gemcitabine: a case report. J Med Case Rep 7:37CrossRefPubMedPubMedCentral El Ammari JE, Ahsaini M, Riyach O et al (2013) Primary signet-ring cell carcinoma of the urinary bladder successfully managed with cisplatin and gemcitabine: a case report. J Med Case Rep 7:37CrossRefPubMedPubMedCentral
14.
go back to reference Hamakawa T, Kojima Y, Naiki T et al (2013) Long-term survival of a patient with invasive signet-ring cell carcinoma of the urinary bladder managed by combined s-1 and Cisplatin adjuvant chemotherapy. Case Rep Urol 2013:915874PubMedPubMedCentral Hamakawa T, Kojima Y, Naiki T et al (2013) Long-term survival of a patient with invasive signet-ring cell carcinoma of the urinary bladder managed by combined s-1 and Cisplatin adjuvant chemotherapy. Case Rep Urol 2013:915874PubMedPubMedCentral
15.
go back to reference Pugashetti N, Yap SA, Lara PN et al (2015) Metastatic signet-ring cell carcinoma of the urinary bladder: a novel management approach to a rare tumour. Can Urol Assoc J 9(3–4):E204-207CrossRefPubMedPubMedCentral Pugashetti N, Yap SA, Lara PN et al (2015) Metastatic signet-ring cell carcinoma of the urinary bladder: a novel management approach to a rare tumour. Can Urol Assoc J 9(3–4):E204-207CrossRefPubMedPubMedCentral
16.
go back to reference Di Maida F, Amorim Aita G, Amorim Aita D (2016) Primary mucinous adenocarcinoma of the urinary bladder with signet-ring cells: description of an uncommon case and critical points in its management. Case Rep Urol 2016:6080859PubMedPubMedCentral Di Maida F, Amorim Aita G, Amorim Aita D (2016) Primary mucinous adenocarcinoma of the urinary bladder with signet-ring cells: description of an uncommon case and critical points in its management. Case Rep Urol 2016:6080859PubMedPubMedCentral
17.
go back to reference Hinduja S, Abdulhaq H, Valliani S et al (2020) Positive response to fluorouracil and oxaliplatin in signet ring cell adenocarcinoma of the bladder presenting with retroperitoneal fibrosis. Cureus 12(7):e9322PubMedPubMedCentral Hinduja S, Abdulhaq H, Valliani S et al (2020) Positive response to fluorouracil and oxaliplatin in signet ring cell adenocarcinoma of the bladder presenting with retroperitoneal fibrosis. Cureus 12(7):e9322PubMedPubMedCentral
19.
go back to reference Bellmunt J, von der Maase H, Mead GM et al (2012) Randomized phase III study comparing paclitaxel/cisplatin/gemcitabine and gemcitabine/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC Intergroup Study 30987. J Clin Oncol 30(10):1107–1113CrossRefPubMedPubMedCentral Bellmunt J, von der Maase H, Mead GM et al (2012) Randomized phase III study comparing paclitaxel/cisplatin/gemcitabine and gemcitabine/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC Intergroup Study 30987. J Clin Oncol 30(10):1107–1113CrossRefPubMedPubMedCentral
Metadata
Title
Primary signet-ring cell carcinoma of the bladder treated with laparoscopic radical cystectomy: a case report
Authors
Yuta Mukae
Kojiro Ohba
Kyohei Araki
Yuichiro Nakamura
Hiromi Nakanishi
Takuji Yasuda
Kensuke Mitsunari
Tomohiro Matsuo
Yasushi Mochizuki
Junji Irie
Ryoichi Imamura
Publication date
06-02-2024
Publisher
Springer Nature Singapore
Published in
International Cancer Conference Journal / Issue 2/2024
Electronic ISSN: 2192-3183
DOI
https://doi.org/10.1007/s13691-023-00648-0

Other articles of this Issue 2/2024

International Cancer Conference Journal 2/2024 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine